Xia Yangbo

Xia Yangbo has extensive work experience in the medical field, spanning various roles and companies. Xia'smost recent position was as the Head of Medical Affairs at Recordati Rare Diseases Inc. since July 2021. Prior to that, they worked as the R&D department Medical Affairs Director for RareStone Group from October 2020 to July 2021. Xia also served as the Medical Affairs, Immunology TA Head at AbbVie from June 2019 to September 2020. Before that, they were the Field Medical Lead in Hepatology at Gilead Sciences from April 2017 to June 2019. Xia'sother previous roles include Medical Affairs Director for Hepatology & Urology at GlaxoSmithKline (China) from August 2014 to February 2017, Medical Affairs Manager in Urology at GlaxoSmithKline (China) from October 2011 to July 2014, Business Development Supervisor at Eisai from September 2009 to September 2011, Nephrologist and Attending Doctor at Shanghai Pudong New Area People's Hospital from July 1996 to August 2009, and Nephrologist at the Hemodialysis Centre in Taza, Maroc from March 2001 to April 2003.

Xia Yangbo pursued their education in the field of medicine. Xia completed a Bachelor's degree in Clinical Medicine from Lanzhou University in the years 1991 to 1996. Following this, they went on to obtain a Master's degree in Nephrology from Soochow University in China, which they accomplished from 2003 to 2006.